7607.Two
7607.TWO operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
Business. 7607.TWO operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
7607.TWO operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
The company's capital structure is characterized by a market price of 13.0 and a market cap of 462,189,000.0, with a price-to-book ratio of 9.07 and a price-to-tangible-book ratio of 9.07, indicating a premium valuation relative to its book value. The enterprise value to EBITDA ratio is negative at -18.62, reflecting the company's current operating losses. The enterprise value to revenue ratio is 23.41, suggesting a high valuation relative to its revenue.
Profitability metrics show a return on equity of -0.5174 and a return on assets of -0.3359, both of which are negative and significantly below industry norms. The company's operating income is -26,013,000.0, and its net income is -26,380,000.0, indicating a substantial loss. The gross profit of 15,795,000.0 is also underperforming compared to industry standards.
The company's revenue is concentrated in the healthcare services and equipment segment, with no disclosed geographic diversification. The lack of geographic exposure data makes it difficult to assess the company's risk from regional economic fluctuations. The company's operating cash flow is -18,474,000.0, and its free cash flow is -20,737,000.0, indicating a cash outflow that could impact its ability to fund operations and growth.
The company's growth trajectory is currently negative, with a net income of -26,380,000.0 and an operating income of -26,013,000.0. The capital expenditure of -257,000.0 suggests minimal investment in new projects or infrastructure. The company's debt-to-equity ratio is 0.44, and its current ratio is 2.24, indicating a moderate level of liquidity but a high risk of insolvency due to its negative net cash position.
The company faces significant liquidity and dilution risks. The risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt highlights the company's financial instability. The company's operating cash flow and free cash flow are both negative, which could necessitate additional financing or equity dilution to maintain operations.
Recent events and filings do not provide specific details on the company's financial health or strategic direction. The company's financial snapshot indicates a challenging operating environment, with significant losses and negative cash flows. The lack of recent events or transcripts makes it difficult to assess the company's response to these challenges or its future plans.
- The company is currently operating at a loss, with a net income of -26,380,000.0 and an operating income of -26,013,000.0.
- The company's valuation is high relative to its book value, with a price-to-book ratio of 9.07.
- The company's liquidity is moderate, but its negative net cash position poses a significant risk.
- The company's profitability metrics are negative, with a return on equity of -0.5174 and a return on assets of -0.3359.
- The company's growth trajectory is negative, with no significant investment in new projects or infrastructure.
- The company's financial instability is highlighted by its negative operating cash flow and free cash flow.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- 7607.TWO Market data — financials · 2026-05-27